Cytotoxicity Evaluation
Cytotoxicity Evaluation - Related Videos
03:00
An Assay to Evaluate Immunodominance in Cytotoxic T Lymphocyte Responses
0 Views •
2025
The video showcases a flow cytometry-based assay for assaying immunodominance in cytotoxic T lymphocytes or CTL responses. Injected fluorescent target cells exhibit varying fluorescence corresponding to immunogenic epitopes. Post-spleen collection and sorting reveal a reduction in high-intensity fluorescent cells, confirming immunodominance in CTL responses.
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
0 Views •
Cited by 64 •
2013
A method for synthesis of air-sensitive titanium and vanadium anticancer agents is described, along with the evaluation of their cytotoxic activity towards human cancer cell line by the MTT Assay.
03:40
β-Galactosidase Assay to Evaluate Drug-Induced Cytotoxicity in Parasites
0 Views •
2023
In this video, we describe a simple and robust method to determine the cytotoxic potential of a trypanocidal drug against a parasite, Trypanosoma cruzi, expressing the β-galactosidase enzyme. β-galactosidase serves as a cell lysis indicator, and its activity can be used to assess the effects of the drug.
02:58
Evaluating Cytotoxicity and Membrane Integrity in Lung Slices via Lactate Dehydrogenase Assay
0 Views •
2025
This video demonstrates the lactate dehydrogenase, LDH assay to measure the cytotoxic effect of a test substance and its effect on the membrane integrity in human precision-cut lung slices. The assay provides a quantitative measure of cell death or damage in the sample.
02:55
An In Vitro Assay for Evaluating Natural Killer Cell Cytotoxicity against Cancer Cells
0 Views •
2025
This video demonstrates performing a lactate dehydrogenase release assay to determine the cytotoxicity of natural killer (NK) cells against the target cancer cells. The assay quantifies the release of the cytoplasmic lactate dehydrogenase enzyme from cancer cells by measuring the absorbance of the red-colored product formed.
FAQs
Metabolic assays indicate whether exposed cells retain biochemical activity, whereas membrane-integrity measurements indicate whether the cell boundary has been disrupted. These readouts describe different consequences of exposure and may not change in parallel. Examining both helps researchers avoid treating every reduction in a measured signal as identical and supports a more precise interpretation of cellular injury.
Dose dependence shows how cellular effects change as the amount of test substance increases. A progressive response can help link exposure level with reduced survival or altered function, while comparisons across doses help distinguish weak effects from stronger toxicity. This information is especially important when evaluating compounds intended for further research or therapeutic development.
Cell survival measurements alone may show that cells are affected without identifying the injury process. Adding endpoints associated with apoptosis, membrane damage, metabolic activity, or proliferation provides more specific biological information. This combination helps determine whether a substance primarily reduces overall viability or produces a recognizable form of cellular damage.
Biochemical assays quantify measurable cellular activities or structural consequences, while imaging-based assays provide visual information about cells and their condition. Using these approaches together can connect numerical changes with observable cellular effects. The resulting evidence supports a broader assessment than relying on a single measurement of cell response.
A typical workflow begins by exposing cultured cells to the chemical, biological agent, drug, or material under investigation. Researchers then measure selected outcomes, such as metabolic activity, membrane integrity, proliferation, or apoptosis, using biochemical or imaging-based assays. Results are compared across exposure levels to characterize changes in cellular survival and function.
Endpoint selection should match the biological question. Metabolic activity can assess retained cellular function, membrane integrity can indicate boundary disruption, proliferation can reveal effects on cell growth, and apoptosis measurements can examine a specific injury pathway. Selecting one or more relevant endpoints allows the study to address both the extent and nature of the cellular response.
The approach supports drug development, toxicology, biomaterials testing, and the selection of safer compounds for research or therapeutic use. In biochemistry, it links exposure to measurable changes in cellular activity and injury. These results help researchers compare candidate substances, identify harmful biological effects, and decide which materials or compounds warrant continued investigation.